X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

DoKaSch Temperature Solutions expands its business in India

Content Team by Content Team
22nd September 2023
in News, Packaging & Logistic
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The Indian pharmaceutical industry worldwide ranks third in pharmaceutical production by volume, according to the Indian government. In order to position itself even better in this region, DoKaSch Temperature Solutions has announced James Savio as Business Development Manager India. “I want to expand the market presence of DoKaSch Temperature Solutions across the Pharmaceuticals main markets in India,” says Savio, “and also ensure that DoKaSch TS is valued as a trusted and reliable safe temperature solutions company in India and global.”

A lot of important pharma and biotech companies are based in India and have taken a lead in the pharma supply chain. They are driving changes at airports where pharmaceuticals are handled – for example, a dedicated facility for temperature controlled sensitive facilities such as cool port and Pharma zone, which is the first of a kind in the country. Indian airports like Bangalore, Mumbai or at Hyderabad International Airport are expanding their infrastructure. Since 2021 DoKaSch TS operates a service station at Hyderabad International Airport. “The companies are looking for reliable temperature solution partners such as DoKaSch Temperature Solutions,” says James Savio. “That’s a big advantage for our company.”

The Pharma sector necessitates complex high-quality logistics in warehousing, transport and handling requirements. Therefore, almost 20 years ago DoKaSch developed the Opticooler®, a high-end active temperature-controlled aircraft container for the pharmaceutical industry that is designed for high reliability and resilience and has been improving it ever since. The Opticooler® can cool and heat using electric compressors and heaters, enabling it to maintain an exact temperature range in any climate – regardless of the ambient temperature and even for weeks if necessary. Besides reliability, availability is another important aspect for the customers of the Opticooler®. That’s why DoKaSch Temperature Solutions has representatives at important strategic pharma sites.

James Savio has many years of experience in the Indian market. His last position was with InterGlobe Air Transport, the general sales agency for Etihad Airways Cargo, as Regional Manager South. During his time at Allied Aviation Private Ltd., he was responsible for Bangalore as Regional Manager. And he worked as Manager Sales and Services for Aviation Travels Private Ltd., the general sales agency of Singapore Airlines Cargo. “Due to my previous career, I’ve gained valuable insights about what the freight customers want and demand,” says DoKaSch TS’ new Business Development Manager India. James Savio is also trained in Quality Management for Pharmaceuticals.

Andreas Seitz, Managing Director at DoKaSch Temperature Solutions: “India is an important market for the production of pharmaceuticals, biosimilars and biotech. With James Savio as Business Development Manager India DoKaSch TS is further expanding its engagement in this region.”

Previous Post

Streamlining Development To Production In Pharma With CDMOs

Next Post

The Impact of Automation On Prefilled Syringe Production

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

The Impact of Automation On Prefilled Syringe Production

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In